Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-58 |
Sentence |
denotes |
Adaptation of Influenza Viruses to Human Airway Receptors. |
T2 |
59-228 |
Sentence |
denotes |
Through annual epidemics and global pandemics, influenza A viruses (IAVs) remain a significant threat to human health as the leading cause of severe respiratory disease. |
T3 |
229-394 |
Sentence |
denotes |
Within the last century, four global pandemics have resulted from the introduction of novel IAVs into humans, with components of each originating from avian viruses. |
T4 |
395-584 |
Sentence |
denotes |
IAVs infect many avian species wherein they maintain a diverse natural reservoir, posing a risk to humans through the occasional emergence of novel strains with enhanced zoonotic potential. |
T5 |
585-781 |
Sentence |
denotes |
One natural barrier for transmission of avian IAVs into humans is the specificity of the receptor-binding protein, hemagglutinin (HA), that recognizes sialic acid-containing glycans on host cells. |
T6 |
782-991 |
Sentence |
denotes |
HAs from human IAVs exhibit "human-type" receptor specificity, binding exclusively to glycans on cells lining the human airway where terminal sialic acids are attached in the α2-6 configuration (NeuAcα2-6Gal). |
T7 |
992-1168 |
Sentence |
denotes |
In contrast, HAs from avian viruses exhibit specificity for "avian-type" α2-3-linked (NeuAcα2-3Gal) receptors, and thus require adaptive mutations to bind human-type receptors. |
T8 |
1169-1352 |
Sentence |
denotes |
Since all human IAV pandemics can be traced to avian origins, there remains ever-present concern over emerging IAVs with human-adaptive potential that might lead to the next pandemic. |
T9 |
1353-1536 |
Sentence |
denotes |
This concern has been brought into focus through emergence of SARS-CoV-2, aligning both scientific and public attention to the threat of novel respiratory viruses from animal sources. |
T10 |
1537-1822 |
Sentence |
denotes |
In this review we summarize receptor-binding adaptations underlying the emergence of all prior IAV pandemics in humans, maintenance and evolution of human-type receptor specificity in subsequent seasonal IAVs, and potential for future human-type receptor adaptation in novel avian HAs. |